Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Director Shareholding

4 Apr 2018 17:06

RNS Number : 8632J
Accrol Group Holdings PLC
04 April 2018
 

4 April 2018

 

Accrol Group Holdings plc

 

(the "Company")

 

Director Shareholding

 

Accrol Group Holdings plc (AIM: ACRL), the AIM-listed independent tissue converter, announces that Dan Wright, Executive Chairman, has advised the Company that he has transferred 415,168 shares in the Company in which he was the direct beneficial owner into the ownership of Gomrath Ltd, a Family Investment Company that he controls.

 

The total shares owned and deemed to be under the control of Dan Wright remains unchanged.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dan Wright

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Transfer of shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

18.52p

415,168

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

4 April 2018

f)

Place of the transaction

London Stock Exchange, AIM

 

 

 

For further information, please contact:

Accrol Group Holdings plc

Gareth Jenkins, Chief Executive Officer

+44 (0) 1254 278 844

Martin Leitch, Interim Chief Finance Officer

+44 (0) 1254 278 844

Zeus Capital Limited (Nominated Adviser & Broker) 

Dan Bate / Andrew Jones

 +44 (0) 161 831 1512

Dominic King / John Goold

+44 (0) 203 829 5000

Belvedere Communications Limited

Cat Valentine (cvalentine@belvederepr.com)

+44 (0) 7715 769 078

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAKLLEEDPEFF
Date   Source Headline
27th Mar 20247:26 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
26th Mar 20243:33 pmRNSTR-1
26th Mar 20241:57 pmPRNForm 8.3 - Accrol Group Holdings plc
26th Mar 20241:01 pmRNSForm 8.3 - Accrol Group Holdings Plc
26th Mar 202412:57 pmRNSForm 8.3 - Accrol Group Holdings PLC
26th Mar 202412:00 pmRNSForm 8.3 - Accrol Group Holdings plc
26th Mar 202411:51 amPRNForm 8.3 - Accrol Group Holdings PLC
26th Mar 202410:02 amPRNForm 8.3 - Accrol Group Holdings plc
26th Mar 20249:17 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
25th Mar 20245:09 pmPRNForm 8.3 - Accrol Group Holdings PLC
25th Mar 20245:03 pmPRNForm 8.3 - Accrol Group Holdings Plc
25th Mar 20243:08 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
25th Mar 20242:31 pmRNSForm 8.3 - Accrol Group Holdings
25th Mar 20242:19 pmRNSForm 8.3 - Accrol Group Holdings Plc
25th Mar 20241:33 pmPRNForm 8.3 - Accrol Group Holdings plc
25th Mar 202411:52 amRNSForm 8.3 - Accrol Group Holdings PLC
25th Mar 202411:00 amPRNForm 8.3 - Accrol Group Holdings plc
25th Mar 202410:51 amRNSForm 8 (DD) - Accrol Group Holdings PLC
25th Mar 202410:24 amRNSForm 8.3 - Accrol Group Holdings PLC
25th Mar 20247:59 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
22nd Mar 20241:24 pmPRNForm 8.3 - Accrol Group Holdings plc
22nd Mar 202412:28 pmRNSForm 8.3 -Accrol Group Holdings PLC
22nd Mar 20248:17 amRNSForm 8.3 - Accrol Group Holdings plc
22nd Mar 20247:00 amRNSRecommended Cash Offer
1st Mar 20243:52 pmRNSTR-1
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTR-1
30th Jan 20247:00 amRNSHalf Year Results
26th Jan 20247:00 amRNSNotice of Results and Investor Webinar
19th Jan 20247:00 amRNSTR-1
18th Jan 20247:00 amRNSAcquisition of Severn Delta Limited
22nd Nov 20237:00 amRNSHalf Year Trading Update
24th Oct 20232:37 pmRNSResult of AGM
18th Oct 202311:52 amRNSTR-1
18th Oct 202311:49 amRNSTR-1
17th Oct 20235:40 pmRNSTR-1
28th Sep 20239:47 amRNSNotice of AGM and Posting of Annual Report 2023
26th Sep 20237:00 amRNSFinal Results 2023
22nd Sep 20237:00 amRNSNotice of Results and Online Presentations
30th Aug 20231:20 pmRNSTR-1
22nd Aug 20237:00 amRNSDirector Dealings
18th Jul 20234:02 pmRNSTR-1
9th Jun 202311:43 amRNSTR-1
16th May 20237:00 amRNSTrading Update
2nd May 20237:00 amRNSBoard Changes
18th Apr 20234:40 pmRNSTR-1
27th Mar 20233:22 pmRNSTR-1
24th Mar 20231:38 pmRNSTR-1
7th Mar 20237:00 amRNSAppointment of Joint Broker
1st Mar 20237:00 amRNSLicensing Agreement with Unilever

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.